Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. 1995

H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
Department of Food and Nutrition, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China, Taiwan.

In this study, the effect of weight loss on blood pressure and various facets of glucose and insulin metabolism was examined in 22 subjects with mild to moderate obesity; 11 with high blood pressure (diastolic blood pressure > 95 mm Hg) and 11 with normal blood pressure (diastolic blood pressure < 90 mm Hg). The two groups were similar in mean (+/- SEM) body mass index at baseline (30.2 +/- 1.0 v 31.6 +/- 1.1 kg/m2), and each group lost approximately 8 kg during the 3-month study period. Blood pressure fell significantly (P < .003) following the 8 kg weight loss in both the normotensive (122 +/- 3/81 +/- 3 to 110 +/- 3/74 +/- 2 mm Hg) and hypertensive (149 +/- 3/98 +/- 1 to 135 +/- 3/86 mm Hg) subjects. Furthermore, the plasma glucose and insulin responses to a 75 g oral glucose load were significantly lower (P < .001) following weight loss. Finally, insulin resistance, as assessed by determining the steady-state plasma glucose (SSPG) concentration at the end of a 180 min infusion of somatostatin, insulin, and glucose, was also lower (P < .002) after the 8 kg weight loss in the normotensive (243 +/- 23 to 172 +/- 15 mg/dL) and hypertensive subjects (266 +/- 18 to 181 +/- 25 mg/dL). Since the steady-state plasma insulin concentrations were, if anything, slightly lower after weight loss in both groups, the lower post-weight loss SSPG values actually underestimate the improvement of insulin resistance. Thus, weight loss of 8 kg in moderately obese individuals leads to significant decreases in blood pressure and plasma glucose and insulin concentrations in response to an oral glucose challenge and degree of insulin resistance.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
October 2005, The American journal of the medical sciences,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
October 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
September 1987, Hypertension (Dallas, Tex. : 1979),
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
September 2001, Hypertension research : official journal of the Japanese Society of Hypertension,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
July 1988, Pediatrics,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
April 1956, American heart journal,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
October 2006, Clinical and experimental hypertension (New York, N.Y. : 1993),
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
December 1987, Journal of clinical hypertension,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
May 2001, Journal of strength and conditioning research,
H Y Su, and W H Sheu, and H M Chin, and C Y Jeng, and Y D Chen, and G M Reaven
January 2005, The American journal of medicine,
Copied contents to your clipboard!